Board of Glaxosmithkline Pharmaceuticals approves change in directorate
At meeting held on 07 January 2021
The Board of Glaxosmithkline Pharmaceuticals at its meeting held on 07 January 2021 has approved the following change in directorate -Resignation of Raju Krishnaswamy as a Director of the Company with effect from 27 January 2021.
Appointment of Mark Dawson as a Non - Executive Director of the company with effect from 28 January 2021.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content